m+Medelevator.RU
← Поиск публикаций
ACS omega · 2026

Lupane Triterpenes with Antileukemia Activity from Maytenus quadrangulata.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Quintão Sandy V M, de Aguilar Mariana G, Souza Lucas C, Freitas Túlio R, Jardim Maria E C Dos S, de Souza Lohanne B E, Sabino Adriano de P, Duarte Lucienir P, F de Sousa Grasiely

Аннотация

Maytenus quadrangulata occurs naturally in the Brazilian biomes Caatinga and Atlantic Forest, and previous studies have demonstrated its potential as a source of bioactive molecules. In light of this, a phytochemical study of the chloroform extract of Maytenus quadrangulata branches was carried out, yielding the new triterpene 30-oxo-2,3-seco-lup-20-(29)-ene-2,3-dioic acid (1) and a mixture containing the new semisynthetic triterpene 25-hydroxy-7-oxofriedelan-3α-yl acetate (2). In addition, seven known compounds were also obtained: friedelan-3-one (3), friedelan-3β-ol (4), friedelan-3α-ol (5), a mixture of long-chain fatty acids of β-sitosterol and lupeol-β-sitosterol alkanoate (6) and lupeol alkanoate (7), friedelane-3,7-dione (8) and 2,3-seco-lup-20-(29)-ene-2,3-dioic acid (9). Structural elucidation of the isolated metabolites was performed using 1H and 13C nuclear magnetic resonance (NMR). The chemical structures of the new compounds, 1 and 2, were confirmed by the analysis of two-dimensional NMR spectra (HSQC, HMBC, COSY, and NOESY). An in vitro cytotoxicity assay against the THP-1 and K-562 leukemia cell lines and an in silico analysis using ADMETLab 3.0 were performed for compounds 1 and 9. The novel triterpene (1) exhibited the highest cytotoxicity and the most favorable drug-like profile, underscoring its potential as an anticancer therapeutic.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты